Center-Authored Papers

Filters: Author is Pereira, Shalini  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Regen LE, Warnock SL, McElhone SW, Williams RP, Witherspoon RC, Fang M, Pereira S.  2013.  Case Study: Chromosome Genomic Array Testing ("Virtual Karyotype") Confirms Loss of Heterozygosity Originally Detected by Hla Typing.. Human immunology. 74:6-6. Abstract
P
Pereira S, Menninger O, McLendon D, Cordell D, Warnock S, McKinney S.  2013.  Donor Selection for Human Cell Transplantation and the Role Played by Anti-Dp Antibodies.. Human immunology. 74:3-3. Abstract
Pereira S, Vayntrub T, Hiraki DD, Cherry AM, Arai S, Dvorak CC, Grumet CF.  2011.  Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants.. Human immunology. 72(6):503-9. Abstract
Pereira S, Perkins S, Lee J-H, Shumway W, LeFor W, Lopez-Cepero M, Wong C, Connolly A, Tan JC, Grumet CF.  2011.  Donor-specific antibody against denatured HLA-A1: clinically nonsignificant? Human immunology. 72(6):492-8. Abstract
N
Nelson WC, Pyo C-W, Vogan D, Wang R, Pyon Y-S, Hennessey C, Smith A, Pereira S, Ishitani A, Geraghty DE.  2015.  An integrated genotyping approach for HLA and other complex genetic systems.. Human immunology. Abstract
L
Leffell MS, Cao K, Coppage M, Hansen JA, Hart JM, Pereira N, Pereira S, Reinsmoen NL, Senitzer D, Smith A et al..  2009.  Incidence of humoral sensitization in HLA partially mismatched hematopoietic stem cell transplantation.. Tissue antigens. 74(6):494-8. Abstract
G
Gutman JA, McKinney SK, Pereira S, Warnock SL, Smith AG, Woolfrey AE, Hansen JA, Delaney C.  2009.  Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies.. Transplantation. 87(3):415-8. Abstract
F
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract